Content |
Pharmaceutical market of Russia
Main article: Pharmaceutical market of Russia
History
2025: Registry Launch
From September 1, 2025, a list of strategically important medicines intended for the therapy of diseases with the highest prevalence among the country's population has been launched in Russia. The new mechanism aims to ensure the sustainability of the national health system and guaranteed access to critically needed medicines. Russian President Vladimir Putin signed a corresponding law earlier.
According to the official Internet portal of legal information, the special register will include drugs used in the prevention and treatment of diseases with the largest share in the structure of morbidity of the Russian population. A prerequisite for the inclusion of medicines in the list will be the provision of their production in Russia.
The government will receive the authority to determine the procedure for forming a list and criteria for the selection of medicines. This will ensure the flexibility and adaptability of the list to the changing medical and economic conditions in the country.
Priority when included in the register will receive drugs for the treatment of socially significant diseases that pose a threat to life or significantly affect the quality of life of patients. We are talking about medicines, without which it is impossible to ensure the continuity of medical care to the population.
The main goal of creating the list is to minimize the risks of a shortage of vital medicines. The system will allow you to identify and eliminate potential threats of interruptions in drug supply in advance, especially during periods of external pressure or economic instability.
The new mechanism will become the basis for long-term planning for the development of pharmaceutical production, optimization of supply chains and acceleration of import substitution processes in the medical industry. This will increase the predictability of the development of the domestic pharmaceutical industry.[1]"
